ArticlebioRxiv : the preprint server for biology2025
ACSS2-Mediated Metabolic-Epigenetic Crosstalk Drives Fulvestrant Resistance and Represents a Novel Therapeutic Target.
Ayça N Mogol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.